Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
United States Supreme Court case citation
|
| gptkbp:citation |
gptkb:Bluebook
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:date |
June 13, 2013
|
| gptkbp:docketNumber |
12-398
|
| gptkbp:fullName |
gptkb:Association_for_Molecular_Pathology_et_al._v._Myriad_Genetics,_Inc.,_et_al.
|
| gptkbp:heldBy |
A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated, but cDNA is patent eligible because it is not naturally occurring.
|
| https://www.w3.org/2000/01/rdf-schema#label |
133 S. Ct. 1761
|
| gptkbp:judge |
gptkb:Supreme_Court_of_the_United_States
|
| gptkbp:legalSubject |
gptkb:US_patent
gptkb:biotechnology |
| gptkbp:opinionBy |
gptkb:Clarence_Thomas
|
| gptkbp:pages |
1761
|
| gptkbp:refersTo |
gptkb:Association_for_Molecular_Pathology_v._Myriad_Genetics,_Inc.
|
| gptkbp:reporter |
gptkb:Supreme_Court_Reporter
|
| gptkbp:unanimousDecision |
true
|
| gptkbp:volume |
133
|
| gptkbp:bfsParent |
gptkb:Bowman_v._Monsanto_Co.
|
| gptkbp:bfsLayer |
6
|